Estrogen-Based Gender-Affirming Hormone Therapy and Subclinical Cardiovascular Disease in Transgender Women with HIV is a research paper published in LGBT Health (2023). On theSindex it has a DataRank of 0.269. It has been cited 5 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.269
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NIDA NIH HHS
Grant: DP2 DA058436
NHLBI NIH HHS
Grant: T32 HL076132
NIAID NIH HHS
Grant: P30 AI050409
NIAID NIH HHS
Grant: P30 AI073961
NIDA NIH HHS
Grant: R00 DA046311
NIAID NIH HHS
Grant: K24 AI120834
FWCI
1.59
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals